Equities

Autobio Diagnostics Co Ltd

603658:SHH

Autobio Diagnostics Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)48.51
  • Today's Change0.530 / 1.10%
  • Shares traded6.04m
  • 1 Year change-10.63%
  • Beta0.3859
Data delayed at least 15 minutes, as of Jun 11 2024 08:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.

  • Revenue in CNY (TTM)4.50bn
  • Net income in CNY1.30bn
  • Incorporated1999
  • Employees5.54k
  • Location
    Autobio Diagnostics Co LtdNo.87 Jingbei Yi Rd.National Eco, Zhengzhou, Henan 450016ZHENGZHOU 450016ChinaCHN
  • Phone+86 37 186506868
  • Fax+86 37 186506767
  • Websitehttps://www.autobio.com.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Junshi Biosciences Co Ltd1.63bn-2.02bn24.15bn2.57k--4.07--14.83-2.06-2.061.666.970.13481.054.11634,034.10-18.18-18.87-23.17-23.1164.0569.13-134.86-88.411.91-215.800.3018--3.38248.394.38--8.36--
Zhejiang Huahai Pharmaceutical Co., Ltd.8.75bn928.37m25.65bn8.22k27.073.01--2.930.63910.63916.025.760.45111.083.461,064,162.004.765.676.908.0759.4460.5210.5511.610.84515.480.504733.550.519910.28-28.8850.517.21--
Kangmei Pharmaceutical Co Ltd4.93bn160.40m26.06bn4.41k161.653.67--5.290.01160.01160.35770.51170.341.402.431,118,464.001.12-17.601.69-32.2422.71-72.783.28-101.190.8746--0.0465--16.60-22.17103.81-22.83-53.51--
Bluestar Adisseo Co13.53bn327.58m26.71bn2.73k81.541.77--1.970.12220.12225.045.630.62864.677.334,947,799.001.525.281.856.9423.8130.312.428.761.044.300.132521.81-9.262.92-95.82-43.752.74-19.09
Shanghai Allist Pharmaceuticals Co Ltd2.48bn915.35m27.86bn1.04k30.436.45--11.212.032.035.529.600.60913.1610.512,379,802.0022.440.640524.190.693394.4896.4236.842.548.22--0.0004211.88155.14237.34393.54--13.53--
Autobio Diagnostics Co Ltd4.50bn1.30bn28.13bn5.54k21.453.18--6.262.242.247.7415.110.40662.084.27811,768.3011.8112.5914.5015.7964.7661.6229.0426.962.81--0.103546.400.045718.154.2816.7017.0311.32
Gan & Lee Pharmaceuticals2.61bn386.85m28.41bn4.48k70.362.57--10.880.67160.67164.5218.380.2340.892610.97582,412.303.478.303.718.8372.2985.3914.8326.447.74--0.000613.6552.311.78177.37-18.301.50--
Humanwell Healthcare Group Co Ltd24.67bn1.96bn31.01bn17.68k15.741.77--1.261.211.2115.2510.730.68333.802.771,395,473.007.216.2013.2912.7245.0242.8210.559.841.2031.560.329318.879.795.65-14.07--8.25--
Data as of Jun 11 2024. Currency figures normalised to Autobio Diagnostics Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

7.78%Per cent of shares held by top holders
HolderShares% Held
Zhong Geng Fund Management Co. , Ltd.as of 30 Sep 202314.81m2.53%
Hwabao WP Fund Management Co., Ltd.as of 29 Jan 20246.77m1.16%
E Fund Management Co., Ltd.as of 31 Dec 20235.71m0.97%
UBS AG (Investment Management)as of 30 Sep 20234.12m0.70%
First Sentier Investors (UK) IM Ltd.as of 29 Feb 20242.73m0.47%
China Asset Management Co., Ltd.as of 31 Dec 20232.66m0.45%
UBS SDIC Fund Management Co., Ltd.as of 30 Jun 20232.58m0.44%
China Universal Asset Management Co., Ltd.as of 31 Dec 20232.16m0.37%
China Southern Asset Management Co., Ltd.as of 31 Dec 20232.13m0.36%
Guotai Asset Management Co., Ltd.as of 31 Dec 20231.93m0.33%
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.